loading

Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
8.40%
3.328
3.633 3.103 3.643 3.752
Operating Income/Loss
3.92%
-6.226
-6.48 -5.213 -6.024 -6.983
Income/Loss From Continuing Operations Before Tax
3.18%
-6.204
-6.408 -5.101 -5.883 -6.834
Income/Loss From Continuing Operations After Tax
3.18%
-6.204
-6.408 -5.101 -5.883 -6.834
Net Income/Loss
3.18%
-6.204
-6.408 -5.101 -5.883 -6.834
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
49.39%
0.7381
1.4585 10.55 3.5199 0.6867
Diluted Average Shares
49.39%
0.7381
1.4585 10.55 3.5199 0.6867
Basic Earnings Per Share
91.34%
-8.40
-4.39 -0.48 -1.67 -9.95
Diluted Earnings Per Share
91.34%
-8.40
-4.39 -0.48 -1.67 -9.95
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.76
price up icon 4.83%
$86.97
price up icon 1.24%
$32.34
price down icon 1.34%
$103.51
price up icon 0.50%
biotechnology ONC
$317.11
price down icon 1.00%
$164.62
price up icon 2.04%
Kapitalisierung:     |  Volumen (24h):